Fdg pet imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation

Nuclear Medicine Communications

Volumn 26, Issue 12, 2005, Pages 1107-1111

  O'Conner, Angus R ^a   Franc, Benjamin L ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Follow up; PET; PTLD; Renal; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; BIOPSY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGING; IMAGING SYSTEM; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCHOOL CHILD;

ADOLESCENT; ADULT; BIOPSY; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE-BODY COUNTING;

EID: 27944501776     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200512000-00010     Document Type: Article

References (9)

1. Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features. Radiology 2000; 217:16-25.
2. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, et al. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant 2005; 19:327-334.
3. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Ann Rev Med 2005; 56:29-44.
4. World Health Organization. Classification of tumours. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (editors): Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001, pp. 1221-1243.
5. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23:1101-1103.
6. Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn International Transplant Tumor Registry experience. Am J Transplant 2005; 5:775-780.
7. Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med 2004; 34:166-179.
8. Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin N Am 2004; 42:1083-1100.
9. 18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005; 106:1376-1381.